服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Type | Clone No |
| Anti-CTLA4/CD152 mAbs [Ipilimumab Biosimilar] (MABL-4815) | MABL-4815 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF8/CD30 mAbs [Iratumumab Biosimilar] (MABL-4816) | MABL-4816 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-SLC1A5 mAbs [Idactamab Biosimilar] (MABL-4786) | MABL-4786 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Dabigatran mAbs [Idarucizumab Biosimilar] (MABL-4787) | MABL-4787 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-LAG3/CD223 mAbs [Ieramilimab Biosimilar] (MABL-4788) | MABL-4788 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-EPHA3 mAbs [Ifabotuzumab Biosimilar] (MABL-4789) | MABL-4789 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-B7H3/CD276 mAbs [Ifinatamab Biosimilar] (MABL-4790) | MABL-4790 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-AGM6/CD79B mAbs [Iladatuzumab Biosimilar] (MABL-4791) | MABL-4791 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TREM2 mAbs [Iluzanebart Biosimilar] (MABL-4792) | MABL-4792 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-MIF mAbs [Imalumab Biosimilar] (MABL-4793) | MABL-4793 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-MCAM/CD146/MUC18 mAbs [Imaprelimab Biosimilar] (MABL-4794) | MABL-4794 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-FCGRT/FcRn mAbs [Imeroprubart Biosimilar] (MABL-4795) | MABL-4795 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-EGFR/ERBB1/HER1 mAbs [Imgatuzumab Biosimilar] (MABL-4796) | MABL-4796 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL2RA/CD25 mAbs [Imneskibart Biosimilar] (MABL-4797) | MABL-4797 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL36R mAbs [Imsidolimab Biosimilar] (MABL-4798) | MABL-4798 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-CD3E;MS4A1/CD20 mAbs [Imvotamab Biosimilar] (MABL-4799) | MABL-4799 | ELISA, FACS, Functional assay, in vivo binding | M, Kappa;Kappa |
| Anti-CCR8/CKR-L1/CDw198 mAbs [Imzokitug Biosimilar] (MABL-4800) | MABL-4800 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-SELP/CD62 mAbs [Inclacumab Biosimilar] (MABL-4801) | MABL-4801 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-SDC1/CD138 mAbs [Indatuximab Biosimilar] (MABL-4802) | MABL-4802 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-SARS-CoV-2 Spike RBD mAbs [Gorivitug Biosimilar] (MABL-4769) | MABL-4769 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn